Syndax Pharmaceuticals Inc (SNDX) Nonoperating Income (Expense) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Syndax Pharmaceuticals Inc quarterly Nonoperating Income (Expense) history and growth rate from 2014 to 2024.
  • Syndax Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $7.11M, a 45.5% increase year-over-year.
  • Syndax Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $22.8M, a 200% increase year-over-year.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $7.11M +$2.23M +45.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $5.43M +$3.12M +135% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q4 2023 $20.6M +$18.2M +751% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $5.21M +$4.95M +1888% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $5.06M +$4.91M +3231% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $4.89M +$5.2M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $2.32M +$1.87M +416% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q4 2022 $2.42M +$3.71M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $262K +$869K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $152K +$728K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$311K +$249K +44.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $449K +$1.01M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q4 2021 -$1.29M +$441K +25.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$607K -$23K -3.94% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$576K -$124K -27.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$560K -$424K -312% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$563K -$768K -375% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-12
Q4 2020 -$1.74M -$3.23M -216% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$584K -$904K -283% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$452K -$910K -199% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$136K -$645K -127% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $205K -$291K -58.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q4 2019 $1.49M -$423K -22.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $320K -$183K -36.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-12
Q2 2019 $458K -$105K -18.7% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-12
Q1 2019 $509K +$156K +44.2% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-12
Q4 2018 $496K +$111K +28.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q4 2018 $1.92M +$763K +66.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $503K +$145K +40.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-05
Q2 2018 $563K +$360K +177% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-05
Q1 2018 $353K +$147K +71.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-05
Q4 2017 $385K +$59K +18.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q4 2017 $1.15M +$1.86M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 $358K +$89K +33.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 $203K -$73K -26.4% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 $206K +$1.78M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 $326K +$910K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q4 2016 -$706K +$2.9M +80.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $269K +$2.14M Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 $276K +$948K Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$1.58M -$1.1M -231% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$584K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q4 2015 -$3.61M -$5.11M -340% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$1.87M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$672K Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$477K Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 $1.5M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.